
Shattuck Labs, Inc.
NASDAQ:STTK
Overview | Financials
Company Name | Shattuck Labs, Inc. |
Symbol | STTK |
Currency | USD |
Price | 0.773 |
Market Cap | 37,040,451 |
Dividend Yield | 0% |
52-week-range | 0.692 - 11.76 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Taylor H. Schreiber M.D., Ph.D. |
Website | https://www.shattucklabs.com |
An error occurred while fetching data.
About Shattuck Labs, Inc.
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD